Fig. 2From: Methylphenidate for attention-deficit/hyperactivity disorder in patients with Smith–Magenis syndrome: protocol for a series of N-of-1 trialsTime schedule of enrolment, interventions, and assessments. Underlined crosses (X) indicate assessments via phone calls. Asterisks (*) indicate the moment with a clinical visit. EDI Emotion Dysregulation Inventory, GAS Goal Attainment Scaling, PQ personal questionnaire, SDQ Strengths and Difficulties QuestionnaireBack to article page